Clinical features of the DOK7 neuromuscular junction synaptopathy
- PMID: 17452375
- DOI: 10.1093/brain/awm072
Clinical features of the DOK7 neuromuscular junction synaptopathy
Abstract
Mutations in DOK7 have recently been shown to underlie a recessive congenital myasthenic syndrome (CMS) associated with small simplified neuromuscular junctions ('synaptopathy') but normal acetylcholine receptor and acetylcholinesterase function. We identified DOK7 mutations in 27 patients from 24 kinships. Mutation 1124_1127dupTGCC was common, present in 20 out of 24 kinships. All patients were found to have at least one allele with a frameshift mutation in DOK7 exon 7, suggesting that loss of function(s) associated with the C-terminal region of Dok-7 underlies this disorder. In 15 patients, we were able to study the clinical features in detail. Clinical onset was usually characterized by difficulty in walking developing after normal motor milestones. Proximal muscles were usually more affected than distal, leading to a 'limb-girdle' pattern of weakness; although ptosis was often present from an early age, eye movements were rarely involved. Patients did not show long-term benefit from anticholinesterase medication and sometimes worsened, and where tried responded to ephedrine. The phenotype can be distinguished from 'limb-girdle' myasthenia associated with tubular aggregates, where DOK7 mutations were not detected and patients respond to anticholinesterase treatments. CMS due to DOK7 mutations are common within our UK cohort and is likely to be under-diagnosed; recognition of the phenotype will help clinical diagnosis, targeted genetic screening and appropriate management.
Similar articles
-
DOK7 congenital myasthenic syndrome: case series and review of literature.BMC Neurol. 2024 Jun 21;24(1):211. doi: 10.1186/s12883-024-03713-0. BMC Neurol. 2024. PMID: 38907197 Free PMC article. Review.
-
Phenotypical spectrum of DOK7 mutations in congenital myasthenic syndromes.Brain. 2007 Jun;130(Pt 6):1497-506. doi: 10.1093/brain/awm068. Epub 2007 Apr 17. Brain. 2007. PMID: 17439981
-
The spectrum of mutations that underlie the neuromuscular junction synaptopathy in DOK7 congenital myasthenic syndrome.Hum Mol Genet. 2012 Sep 1;21(17):3765-75. doi: 10.1093/hmg/dds198. Epub 2012 Jun 1. Hum Mol Genet. 2012. PMID: 22661499
-
Phenotype genotype analysis in 15 patients presenting a congenital myasthenic syndrome due to mutations in DOK7.J Neurol. 2010 May;257(5):754-66. doi: 10.1007/s00415-009-5405-y. Epub 2009 Dec 11. J Neurol. 2010. PMID: 20012313
-
Effective Treatment With Albuterol in DOK7 Congenital Myasthenic Syndrome in Children.Pediatr Neurol. 2016 Jan;54:85-7. doi: 10.1016/j.pediatrneurol.2015.09.019. Epub 2015 Nov 6. Pediatr Neurol. 2016. PMID: 26552645 Review.
Cited by
-
DOK7 congenital myasthenic syndrome: case series and review of literature.BMC Neurol. 2024 Jun 21;24(1):211. doi: 10.1186/s12883-024-03713-0. BMC Neurol. 2024. PMID: 38907197 Free PMC article. Review.
-
When Breathing Becomes a Challenge: A Case of Congenital Myasthenia Gravis in an Indian Neonate With a DOK-7 Gene Mutation.Cureus. 2023 May 10;15(5):e38842. doi: 10.7759/cureus.38842. eCollection 2023 May. Cureus. 2023. PMID: 37303354 Free PMC article.
-
Clinical and Pathologic Features of Congenital Myasthenic Syndromes Caused by 35 Genes-A Comprehensive Review.Int J Mol Sci. 2023 Feb 13;24(4):3730. doi: 10.3390/ijms24043730. Int J Mol Sci. 2023. PMID: 36835142 Free PMC article. Review.
-
Genetic and clinical evaluation of congenital myasthenic syndromes with long-term follow-up: experience of a tertiary center in Turkey.Acta Neurol Belg. 2023 Oct;123(5):1841-1847. doi: 10.1007/s13760-022-02090-0. Epub 2022 Sep 12. Acta Neurol Belg. 2023. PMID: 36094697
-
Effects of Natural Products on Neuromuscular Junction.Curr Neuropharmacol. 2022 Mar 4;20(3):594-610. doi: 10.2174/1570159X19666210924092627. Curr Neuropharmacol. 2022. PMID: 34561984 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
